Home » CORGENTECH TO MERGE WITH ALGORX IN SHARE EXCHANGE
CORGENTECH TO MERGE WITH ALGORX IN SHARE EXCHANGE
Drug developer Corgentech Inc. (CGTK.O: Quote, Profile, Research) said on Monday it agreed to merge with privately held AlgoRx Pharmaceuticals Inc. in a share exchange deal. The combined company will have four products in its pipeline, including Corgentech's experimental treatment for eczema, which is in Phase I/II trials, and an experimental topical local anesthesia being developed by AlgoRx that is in Phase III trials.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May